US 11,717,479 B2
Method of treating epilepsy
James Cassella, Essex, CT (US); Lily Gong, San Jose, CA (US); and Edwin S. Kamemoto, Redwood City, CA (US)
Assigned to ALEXZA PHARMACEUTICALS, INC., Mountain View, CA (US)
Filed by ALEXZA PHARMACEUTICALS, INC., Mountain View, CA (US)
Filed on Apr. 30, 2021, as Appl. No. 17/244,963.
Application 17/244,963 is a continuation of application No. 16/469,143, granted, now 11,241,383, previously published as PCT/US2017/065347, filed on Dec. 8, 2017.
Claims priority of provisional application 62/485,281, filed on Apr. 13, 2017.
Claims priority of provisional application 62/432,353, filed on Dec. 9, 2016.
Prior Publication US 2021/0244661 A1, Aug. 12, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/00 (2006.01); A61P 25/08 (2006.01); A61K 9/16 (2006.01); A61K 31/5517 (2006.01)
CPC A61K 9/0073 (2013.01) [A61K 9/16 (2013.01); A61K 31/5517 (2013.01); A61P 25/08 (2018.01)] 37 Claims
OG exemplary drawing
 
1. A method of treating an epileptic seizure in a subject in need thereof wherein the epileptic seizure is an ongoing seizure that has not yet progressed to status epilepticus,
the method comprising oral administration of alprazolam in the form of a condensation aerosol to the subject,
wherein the subject has a predictable evolution of seizures and
wherein the condensation aerosol is administered using an inhalation device comprising an element for heating an alprazolam composition to form an alprazolam vapor and an element allowing the alprazolam vapor to cool, thereby forming a condensation aerosol,
wherein the method stops the ongoing seizure.